Danaher (DHR) Cash from Financing Activities (2009 - 2026)
Danaher (DHR) recorded quarterly Cash from Financing Activities of $46.0 million in Q1 2026, down 96.52% quarter-over-quarter from $1.3 billion in Q4 2025, and up 103.67% on a YoY basis from $22.6 million in Q1 2025.
Danaher (DHR) Cash from Financing Activities (2009 - 2026) Analysis & Trends
Danaher's Cash from Financing Activities history runs 18 years deep, the most recent figure standing at $46.0 million for Q1 2026.
- In Q1 2026, Cash from Financing Activities rose 103.67% year-over-year to $46.0 million; the TTM figure through Mar 2026 stood at -$1.7 billion (up 82.54% YoY), while the FY2025 annual figure was -$3.0 billion, up 64.69% from the prior year.
- Cash from Financing Activities was $46.0 million for Q1 2026 at Danaher, down from $1.3 billion in the prior quarter.
- In the past five years, Cash from Financing Activities ranged from a high of $2.4 billion in Q3 2023 to a low of -$5.7 billion in Q2 2024.
- Historically, Cash from Financing Activities has averaged -$806.8 million across 5 years, with a median of -$274.0 million in 2022.
- The sharpest annual moves came in 2023 and 2024: Cash from Financing Activities jumped 1162.17% in 2023, then tumbled 2647.6% in 2024.
- A 5-year view of Cash from Financing Activities shows it stood at -$906.0 million in 2022, then sank by 100.77% to -$1.8 billion in 2023, then climbed by 6.98% to -$1.7 billion in 2024, then soared by 178.13% to $1.3 billion in 2025, then plunged by 96.52% to $46.0 million in 2026.
- The last three Cash from Financing Activities figures came in at $46.0 million (Q1 2026), $1.3 billion (Q4 2025), and -$2.8 billion (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 30,529.42 Bn | 30,528.96 Bn | 1.11 Bn | -213.00 Mn |
| 2 | Thermo Fisher Scientific | 183.75 Bn | 180.50 Bn | 7.74 Bn | 1.09 Bn |
| 3 | Danaher | 133.13 Bn | 127.43 Bn | 3.59 Bn | 46.00 Mn |
| 4 | Idexx Laboratories | 46.14 Bn | 45.94 Bn | 722.74 Mn | -211.43 Mn |
| 5 | Agilent Technologies | 38.20 Bn | 36.39 Bn | 990.00 Mn | -144.00 Mn |
| 6 | Natera | 31.50 Bn | 30.40 Bn | 696.04 Mn | 3.76 Mn |
| 7 | Iqvia Holdings | 31.34 Bn | 29.36 Bn | 1.36 Bn | -433.00 Mn |
| 8 | Illumina | 24.51 Bn | 23.36 Bn | 721.00 Mn | -251.00 Mn |
| 9 | Mettler Toledo International | 23.53 Bn | 23.47 Bn | 555.82 Mn | -114.33 Mn |
| 10 | Quest Diagnostics | 22.51 Bn | 22.42 Bn | 942.00 Mn | -152.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 27, 2026 | 46.00 Mn |
| Mar 27, 2026 | 46.00 Mn |
| Dec 31, 2025 | 1.32 Bn |
| Dec 31, 2025 | 1.32 Bn |
| Sep 26, 2025 | -2.78 Bn |
| Sep 26, 2025 | -2.78 Bn |
| Jun 27, 2025 | -247.00 Mn |
| Jun 27, 2025 | -247.00 Mn |
| Mar 28, 2025 | -1.26 Bn |
| Mar 28, 2025 | -1.26 Bn |
| Dec 31, 2024 | -1.69 Bn |
| Dec 31, 2024 | -1.69 Bn |
| Sep 27, 2024 | -845.00 Mn |
| Sep 27, 2024 | -845.00 Mn |
| Jun 28, 2024 | -5.72 Bn |
| Jun 28, 2024 | -5.72 Bn |
| Mar 29, 2024 | -133.00 Mn |
| Mar 29, 2024 | -133.00 Mn |
| Dec 31, 2023 | -1.82 Bn |
| Dec 31, 2023 | -1.82 Bn |